Son et al. found that after reducing GOT2 activity and cutting off the reaction pathway of intracellular glycolysis and TCA, pancreatic cancer and breast cancer cells will undergo dystrophic metabolism and acquire glutamine restriction, thereby inhibiting proliferation [58]. This evidence concerns the gene GOT2 and breast carcinoma.